These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 32754989)
1. Risk of Incident Type 2 Diabetes Mellitus Among Patients With Rheumatoid Arthritis: A Population-Based Cohort Study. Jin Y; Chen SK; Liu J; Kim SC Arthritis Care Res (Hoboken); 2020 Sep; 72(9):1248-1256. PubMed ID: 32754989 [TBL] [Abstract][Full Text] [Related]
2. Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis. Solomon DH; Love TJ; Canning C; Schneeweiss S Ann Rheum Dis; 2010 Dec; 69(12):2114-7. PubMed ID: 20584807 [TBL] [Abstract][Full Text] [Related]
3. Risk of diabetes in patients with rheumatoid arthritis: a 12-year retrospective cohort study. Su CC; Chen IeC; Young FN; Lian IeB J Rheumatol; 2013 Sep; 40(9):1513-8. PubMed ID: 23818711 [TBL] [Abstract][Full Text] [Related]
4. Diabetes incidence in psoriatic arthritis, psoriasis and rheumatoid arthritis: a UK population-based cohort study. Dubreuil M; Rho YH; Man A; Zhu Y; Zhang Y; Love TJ; Ogdie A; Gelfand JM; Choi HK Rheumatology (Oxford); 2014 Feb; 53(2):346-52. PubMed ID: 24185762 [TBL] [Abstract][Full Text] [Related]
5. Risk of diabetes mellitus associated with disease-modifying antirheumatic drugs and statins in rheumatoid arthritis. Ozen G; Pedro S; Holmqvist ME; Avery M; Wolfe F; Michaud K Ann Rheum Dis; 2017 May; 76(5):848-854. PubMed ID: 27836820 [TBL] [Abstract][Full Text] [Related]
6. Incidence and Management of Cardiovascular Risk Factors in Psoriatic Arthritis and Rheumatoid Arthritis: A Population-Based Study. Jafri K; Bartels CM; Shin D; Gelfand JM; Ogdie A Arthritis Care Res (Hoboken); 2017 Jan; 69(1):51-57. PubMed ID: 27696731 [TBL] [Abstract][Full Text] [Related]
7. Incidence and risk factors of major cardiovascular events in rheumatoid arthritis and psoriatic arthritis: A population-based cohort study. Meng H; Lam SH; So H; Tam LS Semin Arthritis Rheum; 2024 Apr; 65():152416. PubMed ID: 38368730 [TBL] [Abstract][Full Text] [Related]
8. Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany. Lyu R; Govoni M; Ding Q; Black CM; Kachroo S; Fan T; Ogbonnaya A; Donga P; Hill J; Makin C Rheumatol Int; 2016 Jan; 36(1):143-53. PubMed ID: 26314368 [TBL] [Abstract][Full Text] [Related]
9. Opioid use surrounding diagnosis and follow-up in patients with ankylosing spondylitis, psoriatic arthritis, and rheumatoid arthritis: Results from US claims databases. Sheahan A; Anjohrin S; Suruki R; Stark JL; Sloan VS Clin Rheumatol; 2024 Jun; 43(6):1897-1907. PubMed ID: 38658403 [TBL] [Abstract][Full Text] [Related]
10. Disease activity, cytokines, chemokines and the risk of incident diabetes in rheumatoid arthritis. Baker JF; England BR; George M; Cannon G; Sauer B; Ogdie A; Hamilton BC; Hunter C; Duryee MJ; Thiele G; Mikuls TR Ann Rheum Dis; 2021 May; 80(5):566-572. PubMed ID: 33397733 [TBL] [Abstract][Full Text] [Related]
11. Economic Burden and Treatment Patterns of Cycling between Conventional Synthetic Disease-modifying Antirheumatic Drugs Among Biologic-treated Patients with Rheumatoid Arthritis. Betts KA; Griffith J; Ganguli A; Li N; Douglas K; Wu EQ Clin Ther; 2016 May; 38(5):1205-16. PubMed ID: 27045991 [TBL] [Abstract][Full Text] [Related]
12. Risk of incident diabetes in patients with gout: a cohort study. Kim SC; Liu J; Solomon DH Arthritis Rheumatol; 2015 Jan; 67(1):273-80. PubMed ID: 25332119 [TBL] [Abstract][Full Text] [Related]
13. Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study. Ogdie A; Yu Y; Haynes K; Love TJ; Maliha S; Jiang Y; Troxel AB; Hennessy S; Kimmel SE; Margolis DJ; Choi H; Mehta NN; Gelfand JM Ann Rheum Dis; 2015 Feb; 74(2):326-32. PubMed ID: 25351522 [TBL] [Abstract][Full Text] [Related]
14. Incidence, sociodemographic factors and treatment penetration of rheumatoid arthritis and psoriatic arthritis in Norway. Kerola AM; Sexton J; Wibetoe G; Rollefstad S; Crowson CS; Mars N; Kazemi A; Haavardsholm EA; Kvien TK; Semb AG Semin Arthritis Rheum; 2021 Oct; 51(5):1081-1088. PubMed ID: 34450506 [TBL] [Abstract][Full Text] [Related]
15. Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study. Peters MJ; van Halm VP; Voskuyl AE; Smulders YM; Boers M; Lems WF; Visser M; Stehouwer CD; Dekker JM; Nijpels G; Heine R; Dijkmans BA; Nurmohamed MT Arthritis Rheum; 2009 Nov; 61(11):1571-9. PubMed ID: 19877093 [TBL] [Abstract][Full Text] [Related]
16. Incidence and Prevalence of Cardiovascular Risk Factors Among Patients With Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis. Radner H; Lesperance T; Accortt NA; Solomon DH Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1510-1518. PubMed ID: 27998029 [TBL] [Abstract][Full Text] [Related]
17. Diabetes mellitus risk in rheumatoid arthritis: reduced incidence with anti-tumor necrosis factor α therapy. Antohe JL; Bili A; Sartorius JA; Kirchner HL; Morris SJ; Dancea S; Wasko MC Arthritis Care Res (Hoboken); 2012 Feb; 64(2):215-21. PubMed ID: 21972198 [TBL] [Abstract][Full Text] [Related]
18. Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis. Solomon DH; Massarotti E; Garg R; Liu J; Canning C; Schneeweiss S JAMA; 2011 Jun; 305(24):2525-31. PubMed ID: 21693740 [TBL] [Abstract][Full Text] [Related]
19. Treatment patterns and health care costs for patients with psoriatic arthritis on biologic therapy: a retrospective cohort study. Zhu B; Edson-Heredia E; Gatz JL; Guo J; Shuler CL Clin Ther; 2013 Sep; 35(9):1376-85. PubMed ID: 23954091 [TBL] [Abstract][Full Text] [Related]
20. Comorbidity in psoriatic arthritis and rheumatoid arthritis. Sinnathurai P; Buchbinder R; Hill C; Lassere M; March L Intern Med J; 2018 Nov; 48(11):1360-1368. PubMed ID: 30047189 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]